Dose Prediction Model Selection for Radiation Therapy Planning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radiation treatment planning methods face challenges in navigating the Pareto surface effectively, especially with a large number of quality metrics, leading to complex navigation and interpretation difficulties, and the need for more versatile approaches to balance clinical goals.
Innovation Solution
Selecting a dose prediction model based on clinical goals allows for the generation of balanced plans using knowledge-based planning, expanding the evaluation region and incorporating Pareto surface navigation with a reduced number of sliders focused on significant quality metrics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If multiple quality metrics are included in MCO to comprehensively evaluate treatment plans, then the evaluation becomes more thorough and clinically meaningful, but the navigation of the Pareto surface becomes more complex and difficult to interpret
Solution Approach 1:
The patent segments the large number of quality metrics into hierarchical groups (e.g., target coverage metrics, organ-at-risk metrics, dose distribution metrics). This segmentation allows planners to navigate the Pareto surface in a structured manner, evaluating metrics within each group separately while maintaining comprehensive evaluation across all groups.
Solution Approach 2:
The patent introduces a new dimension to the Pareto surface navigation by adding clinical goal priorities and weighting schemes. Instead of navigating only in the space of quality metric values, the system allows navigation in an extended space that includes goal importance weights, transforming the navigation problem from purely geometric to include clinical decision-making dimensions.
2Adaptability or versatility
If planners manually navigate the Pareto surface using sliders for each quality metric to find optimal plans, then customization to clinical goals is possible, but the process becomes time-consuming and challenging with many metrics
Solution Approach 1:
The patent implements preliminary action by pre-calculating and storing Pareto optimal plans for various combinations of quality metric weights and clinical goals. When a planner needs to evaluate treatment plans, the system retrieves pre-computed Pareto surfaces rather than calculating them in real-time, significantly reducing planning time while maintaining customization capability.
Solution Approach 2:
The system enables self-service by automatically generating and updating Pareto surfaces based on input clinical goals and quality metrics without requiring manual intervention for each navigation step. The system autonomously performs the optimization calculations and presents results to the planner.
3Productivity
If the Pareto surface is used to represent tradeoffs between clinical goals, then comprehensive optimization is achieved, but it becomes difficult to define clinically meaningful points in the domain
Solution Approach 1:
The patent introduces clinical expert rules and guidelines as intermediaries between the mathematical Pareto surface and clinical decision-making. These rules translate the abstract tradeoffs represented on the Pareto surface into clinically meaningful recommendations by incorporating established medical knowledge and practice patterns.
Solution Approach 2:
The system allows dynamic adjustment of parameter interpretations on the Pareto surface based on clinical context. By changing how metrics are weighted and prioritized according to specific clinical scenarios, the same Pareto surface can reveal different clinically meaningful points for different patient situations.
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
A clinical goal for radiation treatment of a patient is set. A dose prediction model 150 is selected from a number of dose prediction models based on the clinical goal. A radiation treatment plan is then generated for the patient using the dose prediction model that was selected based on the clinical goal.